Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 11 sales; 975 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Dexcom Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 11 filings
- 7 insiders, $8.43M in total
- Insiders trading
- 7
- Net value
- −$8.43M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Dexcom Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Augustinos Nicholas | Director | 29,293Indirect | Sep 16, 2026 | 4 |
| Brown Michael Jon | EVP Chief Legal Compliance Off | 99,885 | Sep 16, 2026 | 11 |
| Sylvain Jereme M | EVP, Chief Financal Officer | 146,828 | Sep 14, 2026 | 5 |
| Boehnlein Glenn S | Director | 5,841 | Sep 10, 2026 | 1 |
| Stern Sadie | EVP Chief People & Culture Off | 126,043 | Aug 28, 2026 | 5 |
| Leach Jacob Steven | President, CEO, and Director | 418,908 | Aug 25, 2026 | 5 |
| Sayer Kevin R | Executive Chair | 302,214 | Aug 24, 2026 | 6 |
| Heller Bridgette P | Director | 29,570 | Aug 13, 2026 | 5 |
| Foletta Mark G | Director | 48,852Indirect | Aug 4, 2026 | 4 |
| Coleman Jon | EVP, Chief Commercial Officer | 95,450 | Jun 5, 2026 | 3 |
| Altman Steven R | Director | 5,565 | Jun 1, 2026 | 2 |
| Gala Renee D | Director | 12,486 | Jun 1, 2026 | 1 |
| Collins Richard Alexander | Director | 5,605 | Jun 1, 2026 | 4 |
| Malady Kyle | Director | 28,242 | Jun 1, 2026 | 1 |
| Driscoll Rimma | Director | 17,319 | Jun 1, 2026 | 1 |
| Ashley Euan A. | Director | 12,731 | Jun 1, 2026 | 2 |
| Osterloh Albert Frederick IV | Director | 8,691 | Jun 1, 2026 | 2 |
| Topol Eric | Director | 380,545Indirect | May 12, 2025 | 0 |
| Dahut Karen M | Director | 17,779Indirect | May 12, 2025 | 0 |
| Dolan Matthew Vincent | EVP, Strategy & Corporate Dev | 42,044 | Jan 30, 2025 | 0 |
| Kahn Barbara | Director | 22,575Indirect | May 21, 2024 | 0 |
| Lawver Teri L | EVP Chief Commercial Officer | 66,641 | Mar 14, 2024 | 0 |
| Regan Barry J. | EVP Operations | 58,469 | Dec 19, 2023 | 0 |
| Flynn Paul R | EVP Global Revenue | 48,949 | Dec 19, 2023 | 0 |
| Pacelli Steven Robert | EVP Managing Director Dexcom V | 124,775 | Nov 27, 2023 | 0 |
| Naganathan Girish | EVP Chief Technology Officer | 47,725 | Nov 27, 2023 | 0 |
| Selvaraj Shelly Ramasamy | SVP Chief Information Officer | 48,453 | Sep 12, 2023 | 0 |
| Skyler Jay S | Director | 63,348Indirect | May 22, 2023 | 0 |
| Balo Andrew K | EVP Regulatory Strategy Clinic | 50,908 | Mar 14, 2023 | 0 |
| Abbey Donald | EVP Global Business Services I | 208,023 | Mar 14, 2023 | 0 |
| Patterson Chad | EVP Global Marketing | 13,675 | May 10, 2022 | 0 |
| Shrishrimal Sumi | SVP Chief Risk Officer | 13,789 | Mar 10, 2022 | 0 |
| Murphy Patrick Michael | EVP, Chief Legal Officer | 16,254 | Sep 13, 2021 | 0 |
| Blackford Quentin S. | Chief Operating Officer | 19,280 | Sep 10, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 17, 2023 (view filing) | Oct 16 | 1 day | Altman Steven RDirector | SSale | −1.00K | $77.58 | −$77.6K | −1.6%60.7K after | 10b5-1 |
| Sep 22, 2023 (view filing) | Sep 22 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −411 | $88.40 | −$36.3K | −0.3%125.6K after | |
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Altman Steven RDirector | SSale | −1.00K | $101.50 | −$101.5K | −1.6%61.7K after | |
| Sep 13, 2023 (view filing) | Sep 12 | 1 day | Heller Bridgette PDirector | SSale | −600 | $106.56 | −$63.9K | −2.5%23.7K after | 10b5-1 |
| Sep 1, 2023 (view filing) | Sep 1 | Same day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −56 | $102.32 | −$5.73K | −0.2%33.6K after | |
| Aug 23, 2023 (view filing) | Aug 23 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −411 | $107.03 | −$44.0K | −0.3%126.0K after | |
| Aug 22, 2023 (view filing) | Aug 22 | Same day | Sylvain Jereme MEVP Chief Financial Officer | SSale | −1.84K | $104.38 | −$192.5K | −2.5%72.9K after | |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Stern SadieEVP Chief Human Resources Offi | SSale | −392 | $110.71 | −$43.4K | −0.5%81.7K after | |
| Jul 24, 2023 (view filing) | Jul 24 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $130.58 | −$53.8K | −0.3%126.4K after | |
| Jul 17, 2023 (view filing) | Jul 14 | 3 days | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −5.03K | $136.00 | −$684.2K | −3.8%126.8K after | |
| Jul 10, 2023 (view filing) | Jul 10 | Same day | Stern SadieEVP Chief Human Resources Offi | SSale | −392 | $128.05 | −$50.2K | −0.5%82.1K after | |
| Jul 10, 2023 (view filing) | Jul 10 | Same day | Regan Barry J.EVP Operations | SSale | −1.99K | $128.05 | −$254.7K | −2.9%66.3K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $125.92 | −$51.9K | −0.3%131.9K after | |
| Jun 15, 2023 (view filing) | Jun 15 | Same day | Selvaraj Shelly RamasamySVP Chief Information Officer | SSale | −2.12K | $130.00 | −$274.9K | −4.0%50.4K after | |
| Jun 12, 2023 (view filing) | Jun 9 | 3 days | Stern SadieEVP Chief Human Resources Offi | SSale | −393 | $121.31 | −$47.7K | −0.5%82.5K after | |
| May 23, 2023 (view filing) | May 23 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $118.65 | −$48.9K | −0.3%132.3K after | |
| May 23, 2023 (view filing) | May 22 | 1 day | Sylvain Jereme MEVP Chief Financial Officer | SSale | −2.40K | $117.58 | −$282.2K | −3.1%74.7K after | |
| May 9, 2023 (view filing) | May 9 | Same day | Stern SadieEVP Chief Human Resources Offi | SSale | −393 | $120.19 | −$47.2K | −0.5%82.9K after | |
| Apr 27, 2023 (view filing) | Apr 27 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −5.03K | $126.00 | −$633.9K | −3.7%132.7K after | |
| Apr 26, 2023 (view filing) | Apr 24 | 2 days | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $124.68 | −$51.4K | −0.3%137.7K after | |
| Apr 20, 2023 (view filing) | Apr 20 | Same day | Leach Jacob StevenEVP Chief Technology Officer | SSale | −30.8K | $125.00 | −$3.85M | −10.6%259.6K after | |
| Apr 20, 2023 (view filing) | Apr 20 | Same day | Regan Barry J.EVP Operations | SSale | −2.21K | $124.50 | −$275.6K | −3.1%68.3K after | |
| Apr 20, 2023 (view filing) | Apr 20 | Same day | Selvaraj Shelly RamasamySVP Chief Information Officer | SSale | −2.01K | $125.00 | −$250.9K | −3.7%52.5K after | |
| Apr 18, 2023 (view filing) | Apr 17 | 1 day | Flynn Paul REVP Global Revenue | SSale | −2.78K | $120.00 | −$333.7K | −5.1%52.1K after | |
| Apr 11, 2023 (view filing) | Apr 10 | 1 day | Stern SadieEVP Chief Human Resources Offi | SSale | −393 | $112.35 | −$44.2K | −0.5%83.3K after | |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Sayer Kevin RPresident CEO and Chairman of | SSale | −20.8K | $114.46 | −$2.38M | −6.0%327.5K after | 3 lots |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Brown Michael JonEVP Chief Legal Officer | SSale | −3.61K | $114.47 | −$413.5K | −5.5%61.9K after | 3 lots |
| Mar 27, 2023 (view filing) | Mar 23 | 4 days | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −5.44K | $116.40 | −$633.4K | −3.8%138.1K after | |
| Mar 17, 2023 (view filing) | Mar 16 | 1 day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −2.30K | $115.00 | −$264.8K | −6.4%33.6K after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Stern SadieEVP Chief Human Resources Offi | SSale | −393 | $111.86 | −$44.0K | −0.5%83.6K after | |
| Mar 14, 2023 (view filing) | Mar 13 | 1 day | Regan Barry J.EVP Operations | SSale | −2.01K | $106.27 | −$213.6K | −2.8%70.5K after | |
| Mar 14, 2023 (view filing) | Mar 13 | 1 day | Flynn Paul REVP Global Revenue | SSale | −2.78K | $106.27 | −$295.6K | −4.8%54.9K after | |
| Mar 14, 2023 (view filing) | Mar 13 | 1 day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −6.23K | $106.27 | −$662.0K | −14.8%35.9K after | |
| Mar 6, 2023 (view filing) | Mar 6 | Same day | Leach Jacob StevenEVP Chief Technology Officer | SSale | −18.1K | $114.74 | −$2.08M | −6.1%281.1K after | 2 lots |
| Mar 6, 2023 (view filing) | Mar 6 | Same day | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −226 | $114.40 | −$25.9K | −0.8%26.5K after | |
| Mar 2, 2023 (view filing) | Mar 1 | 1 day | Sayer Kevin RPresident CEO and Chairman of | SSale | −38.5K | $109.94 | −$4.23M | −10.4%331.3K after | 2 lots |
| Feb 23, 2023 (view filing) | Feb 23 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $111.64 | −$46.0K | −0.3%136.5K after | |
| Feb 22, 2023 (view filing) | Feb 22 | Same day | Sylvain Jereme MEVP Chief Financial Officer | SSale | −2.40K | $114.54 | −$274.9K | −3.6%64.8K after | |
| Jan 31, 2023 (view filing) | Jan 30 | 1 day | Regan Barry J.EVP Operations | SSale | −2.21K | $106.12 | −$234.8K | −3.6%59.4K after | |
| Jan 31, 2023 (view filing) | Jan 30 | 1 day | Sayer Kevin RPresident CEO and Chairman of | SSale | −56.8K | $106.15 | −$6.03M | −13.3%369.8K after | 2 lots |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Sayer Kevin RPresident CEO and Chairman of | SSale | −45.6K | $105.75 | −$4.82M | −9.7%426.6K after | |
| Jan 24, 2023 (view filing) | Jan 23 | 1 day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $107.86 | −$44.4K | −0.3%136.9K after | |
| Dec 27, 2022 (view filing) | Dec 23 | 4 days | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −412 | $112.57 | −$46.4K | −0.3%137.3K after | |
| Dec 8, 2022 (view filing) | Dec 8 | Same day | Flynn Paul REVP Global Revenue | SSale | −8.99K | $123.50 | −$1.11M | −13.9%55.7K after | |
| Nov 22, 2022 (view filing) | Nov 21 | 1 day | Sylvain Jereme MEVP Chief Financial Officer | SSale | −2.40K | $112.62 | −$270.3K | −3.4%67.2K after | |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Dolan Matthew VincentSVP Corporate Strategy-Develop | SSale | −5 | $81.63 | −$408.15 | 0.0%26.5K after | |
| Aug 24, 2022 (view filing) | Aug 23 | 1 day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −1.00K | $84.21 | −$84.2K | −0.7%137.7K after | |
| Jul 25, 2022 (view filing) | Jul 25 | Same day | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −1.00K | $83.07 | −$83.1K | −0.7%138.7K after | |
| Jun 27, 2022 (view filing) | Jun 23 | 4 days | Pacelli Steven RobertEVP Managing Director Dexcom V | SSale | −1.00K | $72.55 | −$72.5K | −0.7%139.7K after | |
| Jun 6, 2022 (view filing) | Jun 6 | Same day | Sylvain Jereme MEVP Chief Financial Officer | SSale | −600 | $301.57 | −$180.9K | −3.3%17.4K after |